Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1872 2
1873 1
1874 9
1875 4
1876 1
1884 1
1887 2
1888 4
1890 1
1891 1
1892 2
1894 1
1897 2
1898 1
1900 1
1904 1
1951 1
1961 1
1967 1
1976 1
1978 1
1980 1
1981 2
1986 1
1987 2
1988 5
1989 6
1990 2
1991 10
1992 6
1993 3
1994 7
1995 3
1997 2
1998 4
1999 4
2000 5
2001 7
2002 8
2003 2
2004 3
2005 6
2006 11
2007 3
2008 3
2009 7
2010 13
2011 17
2012 12
2013 16
2014 17
2015 11
2016 10
2017 4
2018 7
2019 13
2020 8
2021 9
2022 14
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Results by year

Filters applied: . Clear all
Page 1
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall E, van As N; PACE Trial Investigators. Tree AC, et al. Among authors: burnett s. Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13. Lancet Oncol. 2022. PMID: 36113498 Free article. Clinical Trial.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van As N; PACE Trial Investigators. Brand DH, et al. Among authors: burnett s. Lancet Oncol. 2019 Nov;20(11):1531-1543. doi: 10.1016/S1470-2045(19)30569-8. Epub 2019 Sep 17. Lancet Oncol. 2019. PMID: 31540791 Free PMC article. Clinical Trial.
Low-Coordinate Magnesium Sulfide and Selenide Complexes.
Burnett S, Ferns R, Cordes DB, Slawin AMZ, van Mourik T, Stasch A. Burnett S, et al. Inorg Chem. 2023 Oct 9;62(40):16443-16450. doi: 10.1021/acs.inorgchem.3c02132. Epub 2023 Sep 25. Inorg Chem. 2023. PMID: 37747417 Free PMC article.
Development of the self-concept during adolescence.
Sebastian C, Burnett S, Blakemore SJ. Sebastian C, et al. Among authors: burnett s. Trends Cogn Sci. 2008 Nov;12(11):441-6. doi: 10.1016/j.tics.2008.07.008. Trends Cogn Sci. 2008. PMID: 18805040 Review.
Astigmatism.
Burnett SM. Burnett SM. South Med Rec. 1874 Feb;4(2):63-75. South Med Rec. 1874. PMID: 36022252 Free PMC article. No abstract available.
CAMPUS RAPE.
Curtis JN, Burnett S. Curtis JN, et al. Among authors: burnett s. JEMS. 2016 Apr;41(4):48-52. JEMS. 2016. PMID: 27209828 No abstract available.
The role of puberty in the developing adolescent brain.
Blakemore SJ, Burnett S, Dahl RE. Blakemore SJ, et al. Among authors: burnett s. Hum Brain Mapp. 2010 Jun;31(6):926-33. doi: 10.1002/hbm.21052. Hum Brain Mapp. 2010. PMID: 20496383 Free PMC article. Review.
295 results